Tapering Off Suboxone
This is for informational purposes only. Do not use any information in this blog to guide your treatment. This was originally written as a reference for our patients. You must follow the instructions of your provider.
Suboxone Taper & Discontinuation
Medically Reviewed by: Dr. Olusola Olowe, MD, Board-Certified - Addiction Medicine
Last Updated: March 7, 2026
Deciding to taper off Suboxone (buprenorphine/naloxone) is a significant milestone. At Better Life MD, we believe that discontinuation is a process, not an event. A successful taper is built on a foundation of long-term stability and a "low and slow" approach to dose reduction.
1. Determining Readiness
The most critical factor in a successful taper is the duration of stability before the taper begins. Research indicates that patients who remain on Medication-Assisted Treatment (MAT) for longer periods have significantly higher success rates.
The 15-Month Benchmark: Clinical data shows that remaining on buprenorphine for at least 15 months is associated with a 52% reduction in all-cause hospitalizations and a 26% reduction in Emergency Department visits [1].
Lifestyle Stability: Before tapering, you should have a stable living environment, a reliable support system, and at least 6–12 months of consistent, negative drug screenings [2].
Behavioral Skills: You should feel confident in your ability to manage stress and "cravings" using healthy coping mechanisms developed during therapy [3].
2. The Mechanics of the "Low and Slow" Taper
Buprenorphine has an exceptionally long half-life (24–42 hours), which means it leaves the body very slowly. Because of this, withdrawal symptoms often do not peak until 3 to 5 days after a dose reduction [4].
The Proportional Reduction Strategy:
Rather than dropping by a fixed milligram amount, we recommend reducing your dose by a percentage (usually 10% to 25%) every 2 to 4 weeks.
Above 2mg: Reductions are generally easier because brain receptor saturation remains high.
The 2mg Threshold: This is the most difficult stage of a taper. At 2mg, buprenorphine still occupies roughly 40% of the brain's opioid receptors. Dropping from 2mg to 0mg is a much larger physiological change than dropping from 16mg to 8mg [5].
3. Managing Discomfort
To promote comfort during the final stages, we may utilize "comfort medications" to bridge the gap including but not limited to:
Clonidine: Helps manage chills, sweating, and anxiety [3].
Gabapentin: Effectively treats restless leg syndrome (RLS) and sleep disturbances.
Non-Addictive Sleep Aids: To ensure your recovery isn't compromised by insomnia.
Sample Tapering Schedules
These schedules are for illustrative purposes. Plans are based on your individual history and symptoms.
Tapering from 16/4 mg (Higher Dose)
Phase 1: Reduce to 12 mg daily for 4 weeks.
Phase 2: Reduce to 8 mg daily for 4 weeks.
Phase 3: Reduce to 6 mg daily for 4 weeks.
Phase 4: Reduce to 4 mg daily for 4 weeks.
Tapering from 8/2 mg (Moderate Dose)
Phase 1: Reduce to 6 mg daily for 3 weeks.
Phase 2: Reduce to 4 mg daily for 3 weeks.
Phase 3: Reduce to 3 mg daily for 4 weeks.
Phase 4: Reduce to 2 mg daily for 4 weeks.
Tapering from 2/0.5 mg (Low Dose / The "Final Mile")
Step 1: 1.5 mg daily for 2 weeks.
Step 2: 1.0 mg daily for 2 weeks.
Step 3: 0.5 mg daily for 2 weeks.
Step 4: 0.25 mg daily (or 0.5 mg every other day) for 2 weeks before the final discontinuation.
Frequently Asked Questions (FAQ)
1. Why does the taper feel harder when I get to 2mg?
At 2mg, your brain's opioid receptors are still significantly occupied by the medication. Once you drop below this level, the "vacancy" in those receptors becomes more noticeable to your nervous system. This is why we slow the taper down significantly at this stage [5].
2. Is there a risk of overdose if I stop and then relapse?
Yes. This is the primary reason we advocate for long-term treatment. Research shows that patients who stay on treatment for at least 15 months have much lower mortality and overdose rates compared to those who discontinue early [1, 2].
3. What if I start feeling withdrawal symptoms?
If you experience significant discomfort, we simply "pause" the taper. You will stay at your current dose until your body stabilizes. Recovery is not a race; the goal is a permanent transition, not a fast one. Comform medications may provide benefit.
4. Can I use the monthly injection (Sublocade) to stop?
Absolutely. Many patients find that switching to the monthly injection provides the smoothest taper possible. Because the injection dissolves over many months, it creates a "natural taper" that is often imperceptible to the patient [4].
5. How long will the "final jump" symptoms last?
With a proper taper, physical symptoms may be milder and peak within 3–5 days after the last dose, subsiding within two weeks. Mental fatigue and cravings may persist longer, which is why continued therapy is essential [3, 5].
References
Samples, H., Williams, A. R., Crystal, S., & Olfson, M. (2020). Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid. Health Affairs, 39(5), 747-755.
Stringfellow, E. J., et al. (2023). Long-Term Effects of Increasing Buprenorphine Treatment Seeking, Duration, and Capacity on Opioid Overdose Fatalities. Journal of Addiction Medicine, 17(4), 439-446.
Gurley, A. L., et al. (2025). Prehospital Buprenorphine in Treating Symptoms of Opioid Withdrawal – A Descriptive Review. Prehospital Emergency Care, 1-6.
Rodriguez, C. P., & Suzuki, J. (2023). Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended‐release buprenorphine. The American Journal on Addictions, 32(3), 314-317.
Nielsen, S., et al. (2013). A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. Journal of Addiction Medicine, 7(1), 33-38.